Forbes Discusses Stem Cell Research

Posted: June 12, 2011 at 11:23 am



Congressman Forbes discusses the Patients First Act, HR 877, which would intensify research and human clinical trials using stem cells that are ethically obtained and that show evidence of providing near-term clinical benefit for human patients. Additionally, the legislation would promote the creation of pluripotent stem cell lines without the creation, destruction, or discarding of human embryos. Congressman J

Read more:
Forbes Discusses Stem Cell Research

Related Posts